Index

Show indicators by:

Cancer Control Domain
Disease Site

Dashboard
Disease Site
- Breast
- Colorectal
- Lung
- Prostate
- Cervical
- Pancreas
  - Incidence and mortality rates
- Stage Distribution
Province & Territory
1. Prevention
2. Screening
3. Diagnosis
4. Treatment
5. Person-Centred Perspective
6. Research
7. Appropriateness
8. Long-term outcomes
Smoking prevalence
Smoking behaviours in current cancer patients
Smoking cessation
Second-hand smoke exposure
Geographic variation in lung cancer risk
Alcohol consumption
Adult overweight and obesity
Active transportation
Physical inactivity
Human papillomavirus (HPV) vaccination
Fruit and vegetable consumption
Geographic variation in colorectal cancer risk
Cervical cancer screening
Breast cancer screening
Colorectal cancer screening
PSA testing
Screening in underserved populations
Breast cancer diagnosis wait times
Colorectal cancer diagnosis wait times
Capture of stage
Stage distribution
Prostate risk profile
Surgery
Radiation therapy
Systemic therapy
Removal and examination of 12 or more lymph nodes in colon resections
Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
The use of breast-conserving surgery versus mastectomies for breast cancer resections
Breast cancer resections that are mastectomies
High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
Prostate wait times for surgery
Radical prostatectomy: open versus laparoscopic surgery
Radiation therapy wait times
Radiation therapy utilization and capacity
Pre-operative radiation therapy for patients with stage II or III rectal cancer
Post-operative radiation therapy for patients with stage I or II breast cancer
Prostate wait times for radiation therapy
Prostate patterns of care: radiation and surgical treatment
Post-operative chemotherapy for stage III colon cancer patients
Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
Screening for distress
Patient satisfaction
Place of death
Prostate access to palliative radiation
Adult clinical trial participation
Prostate clinical trials participation
Pediatric clinical trial participation
Cancer research investment
Prostate cancer research investment
Breast cancer screening outside of guidelines
Breast cancer mastectomies done as day surgery
Intensive care use in the last two weeks of life
Breast cancer
Lung cancer
Colorectal cancer
Prostate cancer
Pancreatic cancer
Five-year net survival by income quintile for several cancers in Canada

System Performance

About
Reports

Français

Home
Cancer control domain
4. Treatment
Systemic therapy

Systemic therapy

Overview

Indicators

Post-operative chemotherapy for stage III colon cancer patients
Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer

About Us
Careers
Contact
Media centre
Share your feedback
About our new site

Français Language toggle.

Other related sites:

Canadian Partnership for Tomorrow’s Health
Canadian Cancer Research Alliance
Canadian Cancer Trials

facebook
twitter
youtube
linkedin

Questions about cancer?

For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

AODA compliance
Privacy policy
Terms of use
FAQ
Site map
About this site

© Canadian Partnership Against Cancer Corporation